» Articles » PMID: 36672644

Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis

Overview
Journal Biomedicines
Date 2023 Jan 21
PMID 36672644
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B infection is a major public health problem globally leading to chronic liver disease and death, which are influenced by various environmental and host factors including serum 25-hydroxy-vitamin D levels. There is no comprehensive systematic review reporting the association of serum 25-hydroxy-vitamin D levels and different stages of chronic hepatitis B. This study aimed to analyze the association of 25-hydroxy-vitamin D levels in chronic hepatitis B with various determinants and outcomes. A bibliographic search in PubMed, Google Scholar, and Scopus was conducted using the search terms “Vitamin D”, “cholecalciferol”, “calcitriol”, “Hepatitis B”, and “HBV”, which were published until September 2022. Meta-analysis using the “metafor” package in R was conducted with a random effect model. This analysis included 33 studies with 6360 chronic hepatitis B patients. The pooled estimates of serum 25-hydroxy-vitamin D level among CHB cases was 21.05 ng/mL and was significantly lower compared to healthy controls. (p < 0.005). Reduced serum 25-hydroxy-vitamin D level was significantly associated with the severity of liver fibrosis as well as HBe positivity. This analysis suggests that serum 25-hydroxy-vitamin D levels are associated with disease activity and pathobiology, although the exact nature of the cause−effect relationship cannot be discerned from this study.

References
1.
Faul F, Erdfelder E, Buchner A, Lang A . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41(4):1149-60. DOI: 10.3758/BRM.41.4.1149. View

2.
Ko W, Yang Y, Shen F, Wu M, Shih C, Lu M . The Study of Correlation Between Serum Vitamin D Concentrations and HBV DNA Levels and Immune Response in Chronic Hepatitis Patients. Nutrients. 2020; 12(4). PMC: 7230547. DOI: 10.3390/nu12041114. View

3.
Tang L, Covert E, Wilson E, Kottilil S . Chronic Hepatitis B Infection: A Review. JAMA. 2018; 319(17):1802-1813. DOI: 10.1001/jama.2018.3795. View

4.
Downs S, Black N . The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998; 52(6):377-84. PMC: 1756728. DOI: 10.1136/jech.52.6.377. View

5.
Wang C, Tzeng I, Su W, Li C, Lin H, Yang C . The association of vitamin D with hepatitis B virus replication: Bystander rather than offender. J Formos Med Assoc. 2020; 119(11):1634-1641. DOI: 10.1016/j.jfma.2019.12.004. View